Hydroxychloroquine Market to Grow on Autoimmune Disease Demand

Hydroxychloroquine, originally developed as an antimalarial agent, has evolved into a cornerstone therapy for autoimmune disorders such as rheumatoid arthritis and systemic lupus erythematosus. Its immunomodulatory properties help regulate overactive immune responses, reducing inflammation and joint damage. With an established safety profile and hi

read more